Huntington’s Disease Treatment Market Report

Global Huntington’s Disease Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 25, 2022
  • PAGES：151
  • REPORT CODE：GMM776221
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Huntington’s Disease Treatment market report explains the definition, types, applications, major countries, and major players of the Huntington’s Disease Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Valeant Pharmaceuticals

    • Prana Biotechnology

    • Teva Pharmaceuticals

    • Raptor Pharmaceuticals

    • Ionis Pharmaceuticals/ Roche

    • Wave Life Sciences

    By Type:

    • Symptomatic Therapy

    • Disease-Modifying Therapy

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Huntington’s Disease Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Huntington’s Disease Treatment Outlook to 2028- Original Forecasts

    • 2.2 Huntington’s Disease Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Huntington’s Disease Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Huntington’s Disease Treatment Market- Recent Developments

    • 6.1 Huntington’s Disease Treatment Market News and Developments

    • 6.2 Huntington’s Disease Treatment Market Deals Landscape

    7 Huntington’s Disease Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Huntington’s Disease Treatment Key Raw Materials

    • 7.2 Huntington’s Disease Treatment Price Trend of Key Raw Materials

    • 7.3 Huntington’s Disease Treatment Key Suppliers of Raw Materials

    • 7.4 Huntington’s Disease Treatment Market Concentration Rate of Raw Materials

    • 7.5 Huntington’s Disease Treatment Cost Structure Analysis

      • 7.5.1 Huntington’s Disease Treatment Raw Materials Analysis

      • 7.5.2 Huntington’s Disease Treatment Labor Cost Analysis

      • 7.5.3 Huntington’s Disease Treatment Manufacturing Expenses Analysis

    8 Global Huntington’s Disease Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Huntington’s Disease Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Huntington’s Disease Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Huntington’s Disease Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Huntington’s Disease Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Symptomatic Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Disease-Modifying Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Huntington’s Disease Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Huntington’s Disease Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Huntington’s Disease Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.2.2 Canada Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Huntington’s Disease Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.2 UK Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.3 Spain Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.5 France Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.6 Italy Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.8 Finland Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.9 Norway Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.11 Poland Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.12 Russia Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Huntington’s Disease Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.2 Japan Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.3 India Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Huntington’s Disease Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.5.3 Chile Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.5.6 Peru Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Huntington’s Disease Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.6.3 Oman Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Huntington’s Disease Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Huntington’s Disease Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Huntington’s Disease Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Huntington’s Disease Treatment Consumption (2017-2022)

    11 Global Huntington’s Disease Treatment Competitive Analysis

    • 11.1 Valeant Pharmaceuticals

      • 11.1.1 Valeant Pharmaceuticals Company Details

      • 11.1.2 Valeant Pharmaceuticals Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Valeant Pharmaceuticals Huntington’s Disease Treatment Main Business and Markets Served

      • 11.1.4 Valeant Pharmaceuticals Huntington’s Disease Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Prana Biotechnology

      • 11.2.1 Prana Biotechnology Company Details

      • 11.2.2 Prana Biotechnology Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Prana Biotechnology Huntington’s Disease Treatment Main Business and Markets Served

      • 11.2.4 Prana Biotechnology Huntington’s Disease Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Teva Pharmaceuticals

      • 11.3.1 Teva Pharmaceuticals Company Details

      • 11.3.2 Teva Pharmaceuticals Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Teva Pharmaceuticals Huntington’s Disease Treatment Main Business and Markets Served

      • 11.3.4 Teva Pharmaceuticals Huntington’s Disease Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Raptor Pharmaceuticals

      • 11.4.1 Raptor Pharmaceuticals Company Details

      • 11.4.2 Raptor Pharmaceuticals Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Raptor Pharmaceuticals Huntington’s Disease Treatment Main Business and Markets Served

      • 11.4.4 Raptor Pharmaceuticals Huntington’s Disease Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Ionis Pharmaceuticals/ Roche

      • 11.5.1 Ionis Pharmaceuticals/ Roche Company Details

      • 11.5.2 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Main Business and Markets Served

      • 11.5.4 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Wave Life Sciences

      • 11.6.1 Wave Life Sciences Company Details

      • 11.6.2 Wave Life Sciences Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Wave Life Sciences Huntington’s Disease Treatment Main Business and Markets Served

      • 11.6.4 Wave Life Sciences Huntington’s Disease Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    12 Global Huntington’s Disease Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Huntington’s Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Symptomatic Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Disease-Modifying Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Huntington’s Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Huntington’s Disease Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Huntington’s Disease Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Huntington’s Disease Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Huntington’s Disease Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Huntington’s Disease Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Huntington’s Disease Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Huntington’s Disease Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Huntington’s Disease Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Huntington’s Disease Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Huntington’s Disease Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Huntington’s Disease Treatment

    • Figure of Huntington’s Disease Treatment Picture

    • Table Global Huntington’s Disease Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Huntington’s Disease Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Symptomatic Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Disease-Modifying Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Huntington’s Disease Treatment Consumption by Country (2017-2022)

    • Table North America Huntington’s Disease Treatment Consumption by Country (2017-2022)

    • Figure United States Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Huntington’s Disease Treatment Consumption by Country (2017-2022)

    • Figure Germany Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Huntington’s Disease Treatment Consumption by Country (2017-2022)

    • Figure China Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Huntington’s Disease Treatment Consumption by Country (2017-2022)

    • Figure Brazil Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Huntington’s Disease Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Huntington’s Disease Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Huntington’s Disease Treatment Consumption by Country (2017-2022)

    • Figure Australia Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Huntington’s Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Valeant Pharmaceuticals Company Details

    • Table Valeant Pharmaceuticals Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Huntington’s Disease Treatment Main Business and Markets Served

    • Table Valeant Pharmaceuticals Huntington’s Disease Treatment Product Portfolio

    • Table Prana Biotechnology Company Details

    • Table Prana Biotechnology Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prana Biotechnology Huntington’s Disease Treatment Main Business and Markets Served

    • Table Prana Biotechnology Huntington’s Disease Treatment Product Portfolio

    • Table Teva Pharmaceuticals Company Details

    • Table Teva Pharmaceuticals Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Huntington’s Disease Treatment Main Business and Markets Served

    • Table Teva Pharmaceuticals Huntington’s Disease Treatment Product Portfolio

    • Table Raptor Pharmaceuticals Company Details

    • Table Raptor Pharmaceuticals Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Raptor Pharmaceuticals Huntington’s Disease Treatment Main Business and Markets Served

    • Table Raptor Pharmaceuticals Huntington’s Disease Treatment Product Portfolio

    • Table Ionis Pharmaceuticals/ Roche Company Details

    • Table Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Main Business and Markets Served

    • Table Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Product Portfolio

    • Table Wave Life Sciences Company Details

    • Table Wave Life Sciences Huntington’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wave Life Sciences Huntington’s Disease Treatment Main Business and Markets Served

    • Table Wave Life Sciences Huntington’s Disease Treatment Product Portfolio

    • Figure Global Symptomatic Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Disease-Modifying Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Huntington’s Disease Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Huntington’s Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Huntington’s Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Huntington’s Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Huntington’s Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Huntington’s Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Huntington’s Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Huntington’s Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Huntington’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US